EC Orthopaedics

Research Article Volume 4 Issue 2 - 2016

A Comparison Between Methotrexate and Methotrexate with Biological Agents Treatment in Hand Deformities in Patients with Rheumatoid Arthritis

Małgorzata Wisłowska1* and Tomasz Chruściak2

1Rheumatology and Internal Diseases Clinic, Central Clinical Hospital of the Ministry of the Interior, Poland

2Rehabilitation Division, Central Clinical Hospital of the Ministry of the Interior, Poland

*Corresponding Author: Małgorzata Wisłowska, Rheumatology and Internal Diseases Clinic, Central Clinical Hospital of the Ministry of the Interior, Warsaw, 137 Wołoska St. 02-507, Poland.
Received: August 22, 2016; Published: October 14, 2016



Objective: A comparison between the treatment used and hand deformities in patients with RA. The treatment includes conven- tional disease modifying drugs (DMARD) or DMARD and biological agents.

Methods: This study involved 70 female patients admitted between February 2016 and August 2016 to The Central Clinical Hospital in Warsaw to the Rheumatology Department. The group was divided as follows: 35 patients treated with methotrexate (MTX) alone and 35 patients treated with MTX and biological agents. 35 additional healthy volunteers were used as a control group.

Results: 35 hand deformities were noted in the group treated with MTX and biological agents and 42 hand deformities were noted in the group treated with MTX alone. The deformities and their frequencies were as follows: subluxation of the metacarpophalangeal joints (MCPJ) (20.0%) in both groups, ulnar deviation of the MCPJ (14.3 and 20.0%) respectively, radial deviation of the wrist (5.7 and 17.1%), boutonniere deformity of the fingers II - V (20% and 25.7%), swan neck deformity (8.6% and 14.3%), Z deformity of the thumb (11.4 and 2.9%).

According to the results, the average and maximum hand endurance, power grip strength, ability to rotate in the proximal and distal radio-ulnar joint were statistically significantly worse in both RA groups compared with the control group. Between both RA groups, the group treated with MTX and biological agents showed statistically significantly better results in number of rotations in radio-ulnar proximal and distal joints in the dominant hand. In the group treated with both MTX and biological agents, results showed a negative correlation in hand endurance, power grip strength and ability to rotate in the proximal and distal radio-ulnar joint, compared with DAS28 and HAQ. With disease progression, strength, ability and hand endurance decreases. It was observed that in the group treated with MTX alone, hand manipulation ability decreased over time with disease progression, but this correla- tion was not observed in the group treated with both MTX with biological agents. In the group treated with MTX alone, a negative correlation was noted in comparison to HAQ.

Conclusion: Effective management of RA includes slowing down the disease progression. The mode of treatment has an important role as wrist, hands and finger joints are most commonly affected.

keywords:Rheumatoid arthritis; Hand endurance; Handgrip strength; MTX; Biological agents

  1. Porter BJ and Brittain A. “Splinting and exercise in three common deformities in rheumatoid arthritis: a clinical perspective”. Current Opinion in Rheumatology2 (2012): 215-212.
  2. Trieb K and Hofstatter S. “Rheumatoid arthritis of the wrist”. Techniques in Orthopaedics1 (2009): 8-12.
  3. Bielefeld T and Neumann DA. “The unstable metacarpophalangeal joint in rheumatoid arthritis: anatomy, pathomechanics, and physical rehabilitation considerations”. Journal of Orthopaedic & Sports Physical Therapy8 (2005): 502-520.
  4. Terrono AL. “The rheumatoid thumb”. Journal of Hand Surgery2 (2001): 81-92.
  5. Toyama S., et al. “Rheumatoid arthritis of the hand: a five-year longitudinal analysis of clinical and radiographic findings”. Modern Rheumatology1 (2014): 69-77.
  6. Smith GC and Amirfeyz R. “The flexible swan neck deformity in rheumatoid arthritis”. Journal of Hand Surgery7 (2013): 1405- 1407.
  7. Chinchalkar SJ., et al. “Swan neck deformity after distal interphalangeal joint flexion contractures: a biomechanical analysis”. Journal of Hand Therapy4 (2010): 420-425.
  8. Williams K and Terrono AL. “Treatment of boutonniere finger deformity in rheumatoid arthritis”. Journal of Hand Surgery8 (2011): 1388-1393.
  9. Arnett FC., et al. “The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis”. Arthritis and Rheumatism3 (1988): 315-320.
  10. Larsen A and Thoen J. “Hand radiography of 200 patients with rheumatoid arthritis repeated after an interval of one year”. Scandinavian Journal of Rheumatology6 (1987): 395-401.
  11. Prevoo MLL., et al. “Modified disease activity Scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis”. Arthritis and Rheumatism1 (1995): 44-48.
  12. Ferraz MB., et al. “Crosscultural reliability of the physical ability dimension of the health assessment questionnaire”. Journal of Rheumatology6 (1990): 813-817.
  13. Fess EE and Moran C. “Clinical Assessment Recommendations, Indianapolis, American Society of Hand Therapists, (1981).
  14. Longo UG., et al. “Current concepts in the management of rheumatoid hand”. International Journal of Rheumatology 2015 (2015): 648073.
  15. Trieb K. “Treatment of the wrist in rheumatoid arthritis”. Journal of Hand Surgery1 (2008): 113-123.
  16. Madenci E and Gursoy S. “Hand deformity in rheumatoid arthritis and its impact on the quality of life”. The Pain Clinic3 (2003): 255-259.
  17. Chim HW., et al. “Update on the surgical treatment for rheumatoid arthritis”. Journal of Hand Therapy2 (2014): 134-142.
  18. Horsten NC., et al. “Prevalence of hand symptoms, impairment and activity limitations in rheumatoid arthritis in relation to disease duration”. Journal of Rehabilitation Medicine10 (2010): 916-921.
  19. Bodur H., et al. “Hand disability and related variables in patients with rheumatoid arthritis”. Rheumatology International6 (2006): 541-544.
  20. Johnsonn PM and Eberhard K. “Hand deformities are important signs of disease severity in patients with early arthritis”. Rheumatology11 (2009): 1398-1401.
  21. Sheehy C., et al. “Standarized grip strength as an outcome measure in early rheumatoid arthritis”. Scandinavian Journal of Rheumatology4 (2013): 289-293.
  22. Bjork M., et al. “Hand function in women and men with early rheumatoid arthritis. A prospective study over three years (the Swedish TIRA project)”. Scandinavian Journal of Rheumatology1 (2006): 15-19.
  23. Adams J and Burridge J. “Correlation between upper limb functional ability and structural hand impairment in an early rheumatoid population”. Clinical Rehabilitation4 (2004): 405-413.
  24. Cima SR., et al. “Strengthening exercises to improve hand strength and functionality in rheumatoid arthritis with hand deformities: a randomized, controlled trial”. Rheumatology International3 (2013): 725-732.
  25. Bergstra SA., et al. “A systematic review into the effectiveness of hand exercise therapy in the treatment of rheumatoid arthritis. Clinical Rheumatology11 (2014): 1539-1548.
  26. Gunther CM., et al. “Grip strengthin healthy caucasian adults: reference values”. Journal of Hand Surgery 33.4 (2008): 558-565.
  27. Eberhardt K., et al. “Hand function tests are important and sensitive tools for assessment of treatment response in patients with rheumatoid arthritis. Scandinavian Journal of Rheumatology2 (2008): 109-112.

Małgorzata Wisłowska and Tomasz Chruściak. "A Comparison Between Methotrexate and Methotrexate with Biological Agents Treatment in Hand Deformities in Patients with Rheumatoid Arthritis." EC Orthopaedics 4.2 (2016): 454-466.